Affinity Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,530
Closed -$570K 157
2018
Q2
$570K Hold
9,530
0.08% 110
2018
Q1
$384K Buy
9,530
+2,427
+34% +$118K 0.04% 130
2017
Q4
$373K Sell
7,103
-2,883
-29% -$154K 0.04% 114
2017
Q3
$471K Sell
9,986
-1,223
-11% -$49.2K 0.05% 107
2017
Q2
$396K Sell
11,209
-1,350
-11% -$41.7K 0.05% 111
2017
Q1
$297K Buy
+12,559
New +$249K 0.03% 146

Other funds holding EXAS

Affinity Investment Advisors's EXAS Position: Q3 2018 in Review

Affinity Investment Advisors sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 9,530 shares — an estimated $570K sold.

Affinity Investment Advisors first reported a position in EXAS in Q1 2017 and held it in 6 quarters. The position peaked at $570K in Q2 2018. 364 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

  • Affinity Investment Advisors reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
  • Affinity Investment Advisors sold 9,530 Exact Sciences shares in Q3 2018, an estimated $570K.
  • Affinity Investment Advisors first reported a position in Exact Sciences in Q1 2017 and held it in 6 quarters.
  • Affinity Investment Advisors's Exact Sciences position peaked at $570K in Q2 2018.
  • 364 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Affinity Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.